Pharma Now is a monthly B2B magazine that covers trends, technological innovations, and insights in the pharmaceutical and biopharmaceutical sectors. It provides industry news and updates, interviews with leaders, market insights, and regulatory updates.

Pharma Now

Endeavor Bulgaria is a non-profit organization that supports high-impact entrepreneurs in the country by providing them with access to mentorship, talent, and capital. It is part of the global Endeavor network, which operates in nearly 40 markets around the world.

Endeavor Bulgaria

AbbVie Contract Manufacturing provides cGMP contract manufacturing services, focusing on a wide range of pharmaceutical and biotechnology manufacturing needs.

AbbVie Contract Manufacturing

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

De-chu Christopher Tang

Altimmune, Inc.

Pharma Now is a monthly B2B magazine that provides in-depth content related to the pharmaceutical and biopharma sectors, covering industry news, trends, technological innovations, and leadership insights. It caters to professionals within the pharmaceutical industry.

Pharma Now - Empowering Pharma Leadership | 2,996 followers on LinkedIn. The business magazine for pharma leaders | Pharma Now is one of the leading monthly B2B magazines publishing premium content relevant to the pharma industry, providing comprehensively unique coverage of news stories, interviews, features, and analysis on the pharma &amp; biopharma sector by its leading editorial panel. 

Additionally, Pharma Now provides a unique opportunity for the industry to showcase its products and services.

Follow us to get all the updates from the pharma &amp; pharma tech world.

Serial Entrepreneur | Editor-in-Chief for Pharma Now | Passionate about Business, Innovation, Experience Building & Impactful Partnerships

Ravindra Warang

R&D manager at Tyriaq - Advisor at Pharma Now

Mohamed M. Abdol Quader, MSc., H. Dip.education. (Dr MAQ)

Medical Affairs Professional | Medical Strategy, Scientific Communication, Evidence Generation | Open to New Opportunities

Samie Ahmed, Pharm.D., MS

Editor at Pharma Now | Co-Founder & CTO at Omnicon | 50YP @ ICCCS | Techie Pursuing Innovation

Michael Bani

Pharma Now - Empowering Pharma Leadership

Swissport 's Pharma hubs gain certification for excellence 🏅 Know complete story - https://lnkd.in/dEwJfPAv #Swissports #PharmaCertification #Excellence Clarity Pharmaceuticals and Nucleus RadioPharma expand drug production capabilities 🏭 Know complete story - https://lnkd.in/dVzQ_vYf #Clarity #Nucleus #DrugProduction Recce Pharmaceuticals Ltd receives approval for Phase 3 DFI gel trial 🧪 Know complete story - https://lnkd.in/dh2MQeAB #ReccePharma #DFIGel #ClinicalTrials Intas Pharmaceuticals launches Thymotas to support COVID-19 immunity 💉 Know complete story - https://lnkd.in/dFbCsqTK #Intas #Thymotas #COVID19Immunity

India boosts investment in medical device growth ! Know complete story - https://lnkd.in/dywYwZNB #India #MedicalDevices #Investment Ciforadenant targets prostate cancer resistance with new approach 🎯 Corvus Pharmaceuticals Know complete story - https://lnkd.in/dKverrhW #Ciforadenant #ProstateCancer #CancerResearch GI INNOVATION accelerates development of CAR-T therapies 🧬 Know complete story - https://lnkd.in/dfk7UjhB #GIInnovation #CARTherapies #CancerTreatment Merck KGaA Pharmaceutical and Korea Advanced Institute of Science and Technology collaborate to drive innovation forward 🚀 Know complete story - https://lnkd.in/dvb8KHcY #Merck #KAIST #Innovation

FDA Grants VAI Status to Biocon! 💊 Biocon Biologics has received VAI (Voluntary Action Indicated) status from the FDA , a positive milestone that reflects compliance and quality in its manufacturing practices. 🏅 This achievement strengthens Biocon’s position in the global pharmaceutical landscape, paving the way for more advanced healthcare solutions. 🌐 Know complete story - https://lnkd.in/dvYVH7CT #Biocon #FDAApproval #PharmaQuality #HealthcareExcellence

⏳ Time’s Almost Up! Will Your Stall Be the Star of CPHI & PMEC India 2024? This is the last call to put your brand on the map! 🌟 Nominate your stall and get the spotlight you deserve at India’s largest pharma gathering. Imagine industry leaders, potential partners, and key influencers heading straight to your stall. 📈✨ Don’t just attend—dominate the floor! Final chance to secure your spot as a Top Stall to Visit. Ready to make waves? Claim your spotlight now! 👉 https://lnkd.in/gMUkbTfe #CPHIPMECIndia #CPHIPMECIndia2024 #TopStalls #FinalCall #MakeAnImpact #PharmaShowcase #StandOut #PharmaIndia #PharmaInnovation #IndustrySpotlight

🌍 Vaccines vs. Global Threats: A New Era in Healthcare! 💉 We are excited to share our latest interview with Dr. Mahesh Bhalgat , Group CEO of Veeda Clinical Research Limited . In this insightful discussion, Dr. Bhalgat dives deep into the evolving role of vaccines in tackling pressing global health challenges, including antimicrobial resistance and the impact of climate change. 🔍 Key Insights: • The critical role of vaccines in addressing antimicrobial resistance and global health challenges • Insights into the intersection of global warming and vaccine development • How mRNA technology is shaping the future of healthcare • The importance of innovative approaches in pharmaceutical research to impact patient lives 🎥 Watch the full interview here: https://lnkd.in/ddcdM_jR Special thanks to BlueTech Media for their support during the shoot! 🙌🏼 Join us as we explore the future of vaccines and their potential to revolutionize global health! #PharmaNow #Vaccines #GlobalHealth #HealthcareInnovation #PharmaceuticalIndustry #VIDAClinicalResearch

Aurinia Pharmaceuticals Inc. appoints Craig Johnson as new board member 🏛️ Know complete story - https://lnkd.in/dVr9adK3 #Aurinia #BoardAppointment #Leadership Collegium Pharmaceutical, Inc. names Vikram Karnani as its new CEO 👔 Know complete story - https://lnkd.in/dqcmbWZk #Collegium #CEO #Leadership FDA proposes a ban on oral phenylephrine 🚫 Know complete story - https://lnkd.in/dcGFGPpa #FDA #Phenylephrine #Regulations Grünenthal Group completes patient enrolment for Qutenza trial ✅ Averitas Pharma Know complete story - https://lnkd.in/dPx2t87w #Grunenthal #Qutenza #ClinicalTrial

Mustang Bio receives FDA orphan drug designation 🏆 Know complete story - https://lnkd.in/de6U9-X9 #MustangBio #OrphanDrug #FDAApproval Kincell Bio welcomes Stewart McNaull as new CCO 👔 Know complete story - https://lnkd.in/dCW_HZ4D #KincellBio #Leadership #CCO Stephen Bardin joins CalciMedica as Chief Financial Officer 💼 Know complete story - https://lnkd.in/dYGzi2rR #CalciMedica #CFO #Leadership Aptar Pharma expands innovations in respiratory drug delivery 🌬️ Cambridge Healthcare Innovations (CHI) Know complete story - https://lnkd.in/dSttv7Qx #AptarPharma #DrugDelivery #RespiratoryHealth

GC Cell Pioneers CAR-NK Development! 🔬 GC Cell is at the forefront of CAR-NK cell therapy, aiming to create powerful new treatments for cancer. 🌟 This cutting-edge research in cellular therapy holds promise for highly targeted cancer solutions, pushing the boundaries of what's possible in oncology. 🧬 Know complete story - https://lnkd.in/d8jXucXn #CAR_NK #GCCell #CancerResearch #InnovativeTherapies

RNAi Technology Expands to New Frontiers! 🚀 RNAi is breaking new ground, expanding its potential in treating various diseases with innovative therapies. 🧬 This leap forward could revolutionize medicine, offering targeted treatments and better patient outcomes. Exciting times ahead for biotech! 🌍 Know complete story - https://lnkd.in/d4xvbAsp #RNAi #BiotechInnovation #MedicalBreakthrough #FutureOfMedicine

Geron Secures $375M for Rytelo's Development!💊 Geron Corporation has successfully secured $375 million to advance the development of Rytelo, a promising treatment for cancer patients. 🧬 This major funding will support clinical trials and help bring innovative therapies to the forefront. The investment marks a significant step in the fight against cancer, offering new hope to those in need of better treatment options. Know complete story - https://lnkd.in/dfP7HZuR #Geron #Rytelo #CancerTreatment #MedicalInnovation

Metric
Company Name	Pharma Now	Endeavor Bulgaria	AbbVie Contract Manufacturing	Altimmune, Inc.
Symbol				ALT
MSH ID	LIVE:PHARMANOW	BG:ENDEAVOR	COM:ABBVIECONTRACTMFG	COM:ALTIMMUNE
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Consumer Services	Commercial & Professional Services	Healthcare & Health Services	Healthcare
Industry	Pharmaceuticals	Entrepreneurial Support Services	Pharmaceuticals	Biotechnology
Country	IN	BG	US	US
Stage
Employee Count				59
Website	pharmanow.live	endeavor.bg	abbviecontractmfg.com	altimmune.com
LinkedIn	pharma-now	endeavor-bulgaria		altimmune
Founders

Metric
Market Cap		530.35M
Enterprise Value
Monthly Web Traffic	2.79K
Web Traffic Growth	-0.66
Valuation
Raised Capital

Metric
Revenue				426K
Revenue (LTM)
Revenue (NTM)
Gross Profit				-51K
EBITDA				-83.03M
Operating Income				-83.51M
Net Income				-88.45M
EPS				-1.66
Diluted EPS				-1.66
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				-48.84
Operating Profit Margin				-196.03
EBITDA Margin				-194.91
Net Profit Margin				-203.67
Return on Equity				-0.45
Return on Assets				-0.41
Return on Capital Employed				-0.42

PHAR

LIVE:PHARMANOW

Pharma Now

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-6.74
P/B Ratio				3.38
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				1.74K
EV Multiple				-5.07

Metric
Days Sales Outstanding				5.93K
Days Payables Outstanding				10.11K
Days Inventory Outstanding				0.48
Operating Cycle				5.93K
Cash Conversion Cycle				5.89K
Asset Turnover				0.00

Metric
Operating Cash Flow				-76.00M
Free Cash Flow				-76.05M
Cash Flow to Debt				-38.39
Operating Cash Flow/Sales				-130.51
Free Cash Flow Yield				-0.11

Metric
Cash & Equivalents				135.16M
Accounts Receivable				-2.31M
Inventory
Goodwill
Debt to Capitalization				0.01
Debt to Assets
Current Ratio				12.89
Quick Ratio				16.69

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				26.35
R&D to Revenue				243.97
SG&A to Revenue				63.12